Health Condition 1: null- ASA-I and II
Conditions
Interventions
Intervention1: Experimental
Nebulization: Drug
Ropivacaine 60 mg
nebulization group will receive intraperitoneal nebulization of ropivacaine 1%, 3 ml before the start of renal dissection and again at the end of surgery just before deflation of pne
Instillation: Drug
Ropivacaine 100mg
Instillation group will receive 0.5%, 20 ml on kidney after induction of pneumoperitoneum but before dissection of kidney
Sponsors
SGPGIMS
Eligibility
Inclusion criteria
Inclusion criteria: ASA-I-II Scheduled for laparoscopic Nephrectomy Free from pain in preoperative period Not using analgesic drugs before surgery Without cognitive impairment or mental retardation written informed consent
Exclusion criteria
Exclusion criteria: Patient under 18 or over 65 years ASA III,IV or V Emergency or urgency surgery Postoperative admission in an intesive care unit Severe hepatic or renal impairment Pregnancy or lactation Allergy to one of the specific drugs under study Alcohol or drug addiction Acute infection or chronic disease Progressive degenerative disease of CNS Seizures or chronic therapy with antiepileptic drugs Cognitive impairment or mental retardation Any type of communication problem No written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative painTimepoint: In PACU, At 6 hr,at 24 hr,at 48 hr and at the time of discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital morbidityTimepoint: Intraoperative and Postoperative;Hospital stayTimepoint: Time in hours elapsed between surgery and hospital discharge;Postoperative Fentanyl requirementTimepoint: In PACU,At 6 hr,at 24 hr,48 hr,at the time of discharge;Quality of life after surgeryTimepoint: 4 weeks after surgery;Time of Unassisted walkingTimepoint: Time in hours between PACU discharge and when the patient able to walk | — |
Countries
India
Contacts
Public ContactDr Anil Agarwal
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Outcome results
None listed